99% of Kospi Stocks Trade Below Analyst Targets as AI Chips Attract Fund Inflows

According to F&Guide, as of July 7, 231 of 233 Kospi-listed companies with analyst price targets are trading below those targets, with 136 stocks showing discrepancies exceeding 50%. Biotech and secondary battery sectors have fallen out of favor; L&F, a cathode material manufacturer, posted the widest gap at 135.5%, while major pharma names like Yuhan-Kimberly (88.2% discount) and SK Biopharm (71.3%) significantly underperformed targets. Analysts attribute the divergence to capital concentration in AI semiconductors and policy-benefiting sectors, despite solid fundamentals in biotech drug exports and battery shipments outpacing market expectations.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments